West Lafayette, IN, United States of America

Le-Cun Xu

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Endocyte, Inc.. Active years: 2011-2016.

USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Profile: Le-Cun Xu

Introduction

Le-Cun Xu is an innovative inventor based in West Lafayette, Indiana. He holds an impressive portfolio of 4 patents, contributing significantly to the field of anticancer therapeutic agents. His work focuses on the development of tubulysins, which are of great interest in cancer treatment.

Latest Patents

Among his notable inventions are the processes for preparing tubulysins. Tubulysins represent a series of naturally occurring cytotoxic agents that have gained attention for their potential use as anticancer therapeutic agents. In his recent patents, Le-Cun describes various processes and intermediates that are useful for preparing both naturally occurring and non-naturally occurring tubulysins, along with their analogs and derivatives.

Career Highlights

Le-Cun Xu is currently associated with Endocyte, Inc., where he continues to push the boundaries of research and innovation. His expertise in the preparation of tubulysins places him at the forefront of developing new treatments for cancer, showcasing his commitment to enhancing therapeutic options.

Collaborations

Throughout his career, Le-Cun has collaborated with esteemed colleagues such as Iontcho Radoslavov Vlahov and Christopher Paul Leamon. These collaborations highlight the importance of teamwork in advancing scientific research and creating impactful innovations in the field of medical therapeutics.

Conclusion

Le-Cun Xu stands out as a forward-thinking inventor who is making significant strides in the area of anticancer therapies. Through his patents and collaborations, he demonstrates a strong commitment to utilizing his knowledge and skills to develop innovative solutions that could help improve cancer treatment outcomes. His work not only contributes to the scientific community but also holds promise for patients seeking effective therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…